90 related articles for article (PubMed ID: 11752085)
1. Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.
Fueger BJ; Hamilton G; Raderer M; Pangerl T; Traub T; Angelberger P; Baumgartner G; Dudczak R; Virgolini I
J Nucl Med; 2001 Dec; 42(12):1856-62. PubMed ID: 11752085
[TBL] [Abstract][Full Text] [Related]
2. Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
Szepeshazi K; Schally AV; Halmos G; Sun B; Hebert F; Csernus B; Nagy A
Clin Cancer Res; 2001 Sep; 7(9):2854-61. PubMed ID: 11555603
[TBL] [Abstract][Full Text] [Related]
3. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
Smith-Jones PM; Bischof C; Leimer M; Gludovacz D; Angelberger P; Pangerl T; Peck-Radosavljevic M; Hamilton G; Kaserer K; Kofler A; Schlangbauer-Wadl H; Traub T; Virgolini I
Endocrinology; 1999 Nov; 140(11):5136-48. PubMed ID: 10537142
[TBL] [Abstract][Full Text] [Related]
4. Effects of heavy water (D2O) on human pancreatic tumor cells.
Hartmann J; Bader Y; Horvath Z; Saiko P; Grusch M; Illmer C; Madlener S; Fritzer-Szekeres M; Heller N; Alken RG; Szekeres T
Anticancer Res; 2005; 25(5):3407-11. PubMed ID: 16101156
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.
Waser B; Tamma ML; Cescato R; Maecke HR; Reubi JC
J Nucl Med; 2009 Jun; 50(6):936-41. PubMed ID: 19443580
[TBL] [Abstract][Full Text] [Related]
7. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins.
Ahsan H; Reagan-Shaw S; Breur J; Ahmad N
Cancer Lett; 2007 May; 249(2):198-208. PubMed ID: 17005319
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
[TBL] [Abstract][Full Text] [Related]
9. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
10. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
11. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
[TBL] [Abstract][Full Text] [Related]
12. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
Koppan M; Nagy A; Schally AV; Arencibia JM; Plonowski A; Halmos G
Cancer Res; 1998 Sep; 58(18):4132-7. PubMed ID: 9751625
[TBL] [Abstract][Full Text] [Related]
13. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
Kleeff J; Fukahi K; Lopez ME; Friess H; Büchler MW; Sosnowski BA; Korc M
Cancer Gene Ther; 2002 Jun; 9(6):522-32. PubMed ID: 12032663
[TBL] [Abstract][Full Text] [Related]
14. Investigation of cancer cell lines for peptide receptor-targeted drug development.
Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
[TBL] [Abstract][Full Text] [Related]
15. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
Traub T; Petkov V; Ofluoglu S; Pangerl T; Raderer M; Fueger BJ; Schima W; Kurtaran A; Dudczak R; Virgolini I
J Nucl Med; 2001 Sep; 42(9):1309-15. PubMed ID: 11535718
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis of human pancreatic carcinoma cell lines induced by combinations of chemotherapeutic drugs].
Liao Q; Zhao Y; Cai L; Wu Y; Zhu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):122-5. PubMed ID: 12569667
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines.
Chang BK
Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624
[TBL] [Abstract][Full Text] [Related]
18. [Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells].
Xia QS; Ishigaki Y; Sun L; Chen R; Motoo Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):123-7. PubMed ID: 20356498
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
Zagon IS; Smith JP; Conter R; McLaughlin PJ
Int J Mol Med; 2000 Jan; 5(1):77-84. PubMed ID: 10601579
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
Valencak J; Heere-Ress E; Traub-Weidinger T; Raderer M; Schneeberger A; Thalhammer T; Aust S; Hamilton G; Virgolini I; Pehamberger H
Melanoma Res; 2005 Dec; 15(6):523-9. PubMed ID: 16314738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
